SILVERARC CAPITAL MANAGEMENT, LLC – Mersana Therapeutics, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$6.72M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +16.95% | 144.07K shares | 2.79M | $6.76 | 994.07K |
| Q2 2022 | share | Increase | 0.00% | 850K shares | 3.92M | $4.62 | 850K |
| Q3 2021 | share | Decrease | -100.00% | -125.12K shares | -1.69M | $9.43 | 0 |
| Q2 2021 | share | Increase | +400.49% | 100.12K shares | 1.29M | $13.58 | 125.12K |
| Q1 2021 | share | Increase | +132.28% | 14.23K shares | 119K | $16.18 | 25K |
| Q4 2020 | share | Increase | 0.00% | 10.76K shares | 286K | $26.61 | 10.76K |